- Home
- ALXO vs SGRP Comparison
ALXO vs SGRP Comparison
Compare ALXO & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- SGRP
- Stock Information
- Founded
- ALXO 2015
- SGRP 1967
- Country
- ALXO United States
- SGRP United States
- Employees
- ALXO N/A
- SGRP N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- SGRP Business Services
- Sector
- ALXO Health Care
- SGRP Consumer Discretionary
- Exchange
- ALXO Nasdaq
- SGRP Nasdaq
- Market Cap
- ALXO 28.3M
- SGRP 27.8M
- IPO Year
- ALXO 2020
- SGRP 1996
- Fundamental
- Price
- ALXO $0.42
- SGRP $1.02
- Analyst Decision
- ALXO Strong Buy
- SGRP
- Analyst Count
- ALXO 6
- SGRP 0
- Target Price
- ALXO $3.54
- SGRP N/A
- AVG Volume (30 Days)
- ALXO 515.3K
- SGRP 41.3K
- Earning Date
- ALXO 05-08-2025
- SGRP 05-20-2025
- Dividend Yield
- ALXO N/A
- SGRP N/A
- EPS Growth
- ALXO N/A
- SGRP N/A
- EPS
- ALXO N/A
- SGRP 0.50
- Revenue
- ALXO N/A
- SGRP $228,869,000.00
- Revenue This Year
- ALXO N/A
- SGRP N/A
- Revenue Next Year
- ALXO N/A
- SGRP N/A
- P/E Ratio
- ALXO N/A
- SGRP $2.12
- Revenue Growth
- ALXO N/A
- SGRP N/A
- 52 Week Low
- ALXO $0.44
- SGRP $1.00
- 52 Week High
- ALXO $17.50
- SGRP $3.12
- Technical
- Relative Strength Index (RSI)
- ALXO 31.14
- SGRP 28.07
- Support Level
- ALXO $0.49
- SGRP $1.00
- Resistance Level
- ALXO $0.55
- SGRP $1.08
- Average True Range (ATR)
- ALXO 0.05
- SGRP 0.06
- MACD
- ALXO 0.00
- SGRP 0.01
- Stochastic Oscillator
- ALXO 4.92
- SGRP 10.00
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.